Hodgkin's lymphoma diagnostic study of choice: Difference between revisions
Jump to navigation
Jump to search
Shyam Patel (talk | contribs) No edit summary |
Nick Menzel (talk | contribs) |
||
| Line 6: | Line 6: | ||
The diagnostic study of choice for Hodgkin's lymphoma is excisional lymph node biopsy. A bone marrow biopsy is an alternative to a lymph node biopsy. | The diagnostic study of choice for Hodgkin's lymphoma is excisional lymph node biopsy. A bone marrow biopsy is an alternative to a lymph node biopsy. | ||
==Diagnostic study of choice== | ==Diagnostic study of choice== | ||
*The diagnostic study of choice for Hodgkin's lymphoma is excisional lymph node biopsy. An excisional biopsy is needed because it preserves the architecture of the lymph node and allows for precise determination of the type of lymphoma. Fine needle aspiration biopsy is insufficient. In addition to light microscopy evaluation of the excisional biopsy samples, the immunophenotypic analysis with immunohistochemistry helps to determine Hodgkin's lymphoma subtypes and distinguish Hodgkin's lymphoma from T cell rich large B cell lymphoma and anaplastic large cell lymphoma. The presence of Reed-Sternberg | *The diagnostic study of choice for Hodgkin's lymphoma is excisional lymph node biopsy. An excisional biopsy is needed because it preserves the architecture of the lymph node and allows for precise determination of the type of lymphoma. Fine needle aspiration biopsy is insufficient. In addition to light microscopy evaluation of the excisional biopsy samples, the immunophenotypic analysis with immunohistochemistry helps to determine Hodgkin's lymphoma subtypes and distinguish Hodgkin's lymphoma from T cell rich large B cell lymphoma and anaplastic large cell lymphoma. The presence of Reed-Sternberg cells is diagnostic for classic Hodgkin's lymphoma. The Reed-Sternberg cells of classic Hodgkin's lymphoma particularly express CD15 and CD30 and do not present CD3 or CD45. Flow cytometry is an effective method in differentiating between classic Hodgkin's lymphoma, nodular lymphocyte predominant Hodgkin's lymphoma, and T cell rich large B cell lymphoma based upon the presence of specific T cell populations.<ref name="pmid27365459">{{cite journal| author=Vardhana S, Younes A| title=The immune microenvironment in Hodgkin lymphoma: T cells, B cells, and immune checkpoints. | journal=Haematologica | year= 2016 | volume= 101 | issue= 7 | pages= 794-802 | pmid=27365459 | doi=10.3324/haematol.2015.132761 | pmc=5004458 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27365459 }} </ref> | ||
*A bone marrow biopsy can also be done to diagnose Hodgkin lymphoma if there is sufficient evidence of marrow involvement (i.e. presence of cytopenias). Hodgkin lymphoma cells originate in the bone marrow, which is the site of B cell production and maturation. A length of 2cm of the core biopsy is generally needed for diagnosis, which is in contrast to diagnostic requirements for leukemias. A bone marrow is not the diagnostic study of choice for Hodgkin lymphoma if a lymph node can be biopsied. | *A bone marrow biopsy can also be done to diagnose Hodgkin lymphoma if there is sufficient evidence of marrow involvement (i.e. presence of cytopenias). Hodgkin lymphoma cells originate in the bone marrow, which is the site of B cell production and maturation. A length of 2cm of the core biopsy is generally needed for diagnosis, which is in contrast to diagnostic requirements for leukemias. A bone marrow is not the diagnostic study of choice for Hodgkin lymphoma if a lymph node can be biopsied. | ||
Revision as of 16:36, 15 January 2019
|
Hodgkin's lymphoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hodgkin's lymphoma diagnostic study of choice On the Web |
|
American Roentgen Ray Society Images of Hodgkin's lymphoma diagnostic study of choice |
|
Risk calculators and risk factors for Hodgkin's lymphoma diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [3]
Overview
The diagnostic study of choice for Hodgkin's lymphoma is excisional lymph node biopsy. A bone marrow biopsy is an alternative to a lymph node biopsy.
Diagnostic study of choice
- The diagnostic study of choice for Hodgkin's lymphoma is excisional lymph node biopsy. An excisional biopsy is needed because it preserves the architecture of the lymph node and allows for precise determination of the type of lymphoma. Fine needle aspiration biopsy is insufficient. In addition to light microscopy evaluation of the excisional biopsy samples, the immunophenotypic analysis with immunohistochemistry helps to determine Hodgkin's lymphoma subtypes and distinguish Hodgkin's lymphoma from T cell rich large B cell lymphoma and anaplastic large cell lymphoma. The presence of Reed-Sternberg cells is diagnostic for classic Hodgkin's lymphoma. The Reed-Sternberg cells of classic Hodgkin's lymphoma particularly express CD15 and CD30 and do not present CD3 or CD45. Flow cytometry is an effective method in differentiating between classic Hodgkin's lymphoma, nodular lymphocyte predominant Hodgkin's lymphoma, and T cell rich large B cell lymphoma based upon the presence of specific T cell populations.[1]
- A bone marrow biopsy can also be done to diagnose Hodgkin lymphoma if there is sufficient evidence of marrow involvement (i.e. presence of cytopenias). Hodgkin lymphoma cells originate in the bone marrow, which is the site of B cell production and maturation. A length of 2cm of the core biopsy is generally needed for diagnosis, which is in contrast to diagnostic requirements for leukemias. A bone marrow is not the diagnostic study of choice for Hodgkin lymphoma if a lymph node can be biopsied.
References
- ↑ Vardhana S, Younes A (2016). "The immune microenvironment in Hodgkin lymphoma: T cells, B cells, and immune checkpoints". Haematologica. 101 (7): 794–802. doi:10.3324/haematol.2015.132761. PMC 5004458. PMID 27365459.